Irina Chaikov, MD | |
500 University Dr, Hershey, PA 17033-2360 | |
(717) 531-8521 | |
Not Available |
Full Name | Irina Chaikov |
---|---|
Gender | Female |
Speciality | Otolaryngology |
Location | 500 University Dr, Hershey, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407177249 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | MT198219 (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Irina Chaikov, MD 500 University Dr, Hershey, PA 17033-2360 Ph: (717) 531-8521 | Irina Chaikov, MD 500 University Dr, Hershey, PA 17033-2360 Ph: (717) 531-8521 |
News Archive
Research led by the University of Birmingham, published today in Science Translational Medicine, has discovered that a drug commonly used to treat patients with either obesity or Type II diabetes could be used as a novel new way to lower brain pressure.
As part of the German government's High-Tech-Strategy 2025, the Federal Ministry of Education and Research is funding an interdisciplinary research group that aims to use an innovative circuit technology to solve a central problem of genetic investigation of human single cells.
A new epidemiological study has found that among women who have never used menopausal hormone therapy, obese women are at an increased risk of developing ovarian cancer compared with women of normal weight. Published in the February 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the research indicates that obesity may contribute to the development of ovarian cancer through a hormonal mechanism.
Among patients with active cancer and acute symptomatic venous thromboembolism (VTE; blood clots in the deep veins), the use of the low molecular-weight heparin tinzaparin daily for 6 months compared with warfarin did not significantly reduce recurrent VTE and was not associated with reductions in overall death or major bleeding, but was associated with a lower rate of clinically relevant nonmajor bleeding, according to a study in the August 18 issue of JAMA.
› Verified 4 days ago
Neerav Goyal, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 717-531-8521 | |
Dr. Scott Walen, M.D., FRCSC Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 Fax: 717-531-4907 | |
Dr. Jessyka G Lighthall, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 | |
Dr. Mark E. Whitaker, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 717-531-6822 Fax: 717-531-4907 | |
Sohrab Sohrabi, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 | |
Heather Schopper, Otolaryngology Medicare: Medicare Enrolled Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 |